Siroz olgularında dinamik BT bulgularının klinik ve laboratuvar bulgularıyla ilişkisi

















































39. Thomas R. Rıley Iıı, M.D., M.S., And Ahsan M. Bhattı, M.D. Preventive Strategies in Chronic Liver Disease: Part II. Cirrhosis. Am Fam Physician 2001; 64:1735-1740. 40. Fattovich G, Stroffolini T, Zagni I, Donato F. Hepatocellular carcinoma in cirrhosis: incidenc and risk factors. Gastroenterology 2004; 127:35-50 41. Forner A, Amelia J. Hessheimer M, Real I, Bruix J. Treatment of hepatocellular carcinoma Critical Reviews in Oncology/Hematology. 2006;.60:89-98. 42. Okuda, K, Ohtsuki, T, Obata, H, et al. Natural history of hepatocellular carcinoma and prognosis in relation to treatment. Study of 850 patients. Cancer 1985; 56:918-928. 43. Angela D. Levy, Ltc, Mc. Malıgnant Lıver Tumors. Hepatıc Imagıng And Interventıon 2002;6:147-164. 44. Maringhini A, Cottone M, Sciarrino E, Marceno MP, La Seta F, Fusco G, et al. Ultrasonography and alpha-fetoprotein in diagnosis of hepatocellular carcinoma in cirrhosis. Dig Dis Sci 1988; 33:47-51. 45. Peterson MS, Baron RL. Radiographic diagnosis of hepatocellular carcinoma. Clin Liver Dis 2001; 5:123-144. 46. Aoyagi Y, Suzuki Y, Isemura M, Nomoto M, Sekine C, Igarashi K, Ichida F. The fucosylation index of alpha-fetoprotein and its usefulness in the early diagnosis of hepatocellular carcinoma. Cancer 1988;61:76974. lectin-reactive alpha-fetoproteins in early detection of hepatocellular carcinoma. Cancer Res 1993;53:541923 47. Shimizu A, Shiraki K, Ito T, Sugimoto K, Sakai T, Ohmori S, Murata K, et al. Sequential fluctuation pattern of serum desgamma- carboxy prothrombin levels detected by high sensitive electrochemiluminescence system as an early predictive marker for hepatocellular carcinoma in patients with cirrhosis. Int J Mol Med 2002;9:24550. 48. Toyoda H, Kumada T, Kiriyama S, Sone Y, Tanikawa M, Hisanaga Y, Yamaguchi A, et al. Prognostic significance of simultaneous measurement of three tumor markers in patients with hepatocellular carcinoma. Clin Gastroenterol Hepatol 2006;4:1117.
34



45. SAYFAYA BENZER SAYFALAR

Hepatosellüler kanserli hastaların klinik ve epidemiyolojik özellikleri ve bunların klinik seyir ve prognoz üzerine etkileri - Sayfa 98
171.Lok, AS, Lai, CL. Alpha-fetoprotein monitoring in Chinese patients with chronic hepatitis B virus infection: Role in the early detection of hepatocellular carcinoma. Hepatology 1989; 9:110. 172.Weitz, IC, Liebman, HA. Des-gamma-carboxy (abnormal) prothrombin and hepatocellular carcinoma: A critical review. Hepatology 1993; 18:990. 173.Nakamura, S, Nouso, K, Sakaguchi, K, et al. Sensitivity a...
Hepatosellüler karsinomada p53 kodon72 ve MDM2 SNP309 polimorfizimlerinin sıklığı ve bu polimorfizmlerin tümöre ait karakteristiklerle karşılaştırılması P53 codon72 and MDM2 SNP309 polymorphisms in hepatocellular carcinoma and comparison of them with tumor characteristics - Sayfa 117
119. Yu JS, Kim KW, Kim EK. Contrast enhancement of small hepatocellular carcinoma: usefulness of three successive early image acquisitions during multiphase dynamic MR imaging. Am J Roentgenol.1999; 173:597-604. 120. Lim JH, Kim CK, Lee WJ. Detection of hepatocellular carcinomas and dysplastic nodules in cirrhotic livers: accuracy of helical CT in transplant patients. Am J Roentgenol. 2000; 175:...
Hepatosellüler karsinomda sağkalımı etkileyen faktörler - Sayfa 111
57. Meyers WC, Callery MP, Schaffer BK, Shah SA: Staging, resection and ablation of liver tumors. Ed. CM Towsend: "Sabiston Textbook of Surgery". 16th edition, W.B. Saunders Company, 2001, Chapter 48, p. 1035-1043. 58. Moradpour D, Blum HE. Pathogenesis of hepatocellular carcinoma. Eur J Gastroenterol Hepatol 2005;17.477-483. 59. Sheu JC, Sung JL, Chen DS, et al. Growth rate of asymptomatic hepa...

45. SAYFADAKI ANAHTAR KELIMELER

hepatol
gastroenterol
carcinoma
hepatocellular
liver
clin


45. SAYFA ICERIGI

39. Thomas R. Rıley Iıı, M.D., M.S., And Ahsan M. Bhattı, M.D. Preventive Strategies in Chronic Liver Disease: Part II. Cirrhosis. Am Fam Physician 2001; 64:1735-1740. 40. Fattovich G, Stroffolini T, Zagni I, Donato F. Hepatocellular carcinoma in cirrhosis: incidenc and risk factors. Gastroenterology 2004; 127:35-50 41. Forner A, Amelia J. Hessheimer M, Real I, Bruix J. Treatment of hepatocellular carcinoma Critical Reviews in Oncology/Hematology. 2006;.60:89-98. 42. Okuda, K, Ohtsuki, T, Obata, H, et al. Natural history of hepatocellular carcinoma and prognosis in relation to treatment. Study of 850 patients. Cancer 1985; 56:918-928. 43. Angela D. Levy, Ltc, Mc. Malıgnant Lıver Tumors. Hepatıc Imagıng And Interventıon 2002;6:147-164. 44. Maringhini A, Cottone M, Sciarrino E, Marceno MP, La Seta F, Fusco G, et al. Ultrasonography and alpha-fetoprotein in diagnosis of hepatocellular carcinoma in cirrhosis. Dig Dis Sci 1988; 33:47-51. 45. Peterson MS, Baron RL. Radiographic diagnosis of hepatocellular carcinoma. Clin Liver Dis 2001; 5:123-144. 46. Aoyagi Y, Suzuki Y, Isemura M, Nomoto M, Sekine C, Igarashi K, Ichida F. The fucosylation index of alpha-fetoprotein and its usefulness in the early diagnosis of hepatocellular carcinoma. Cancer 1988;61:76974. lectin-reactive alpha-fetoproteins in early detection of hepatocellular carcinoma. Cancer Res 1993;53:541923 47. Shimizu A, Shiraki K, Ito T, Sugimoto K, Sakai T, Ohmori S, Murata K, et al. Sequential fluctuation pattern of serum desgamma- carboxy prothrombin levels detected by high sensitive electrochemiluminescence system as an early predictive marker for hepatocellular carcinoma in patients with cirrhosis. Int J Mol Med 2002;9:24550. 48. Toyoda H, Kumada T, Kiriyama S, Sone Y, Tanikawa M, Hisanaga Y, Yamaguchi A, et al. Prognostic significance of simultaneous measurement of three tumor markers in patients with hepatocellular carcinoma. Clin Gastroenterol Hepatol 2006;4:1117.
34

İlgili Kaynaklar







single.php